Research programme: ASIC and NGF/p75 antagonists - PainCeptor
Alternative Names: PPC-1807; PPC-5383; PPC-5692; PPC-778Latest Information Update: 25 Oct 2011
Price :
$50 *
At a glance
- Originator PainCeptor Pharma Corporation
- Class Small molecules
- Mechanism of Action ASIC channel antagonists; Nerve growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 31 Dec 2009 Discontinued - Preclinical for Pain in Canada (unspecified route)
- 15 Sep 2008 Preclinical development is ongoing
- 24 Nov 2006 Preclinical data have been added to the adverse events and pharmacokinetics section